Skip To Main Content
Zhe-ran Liu on Muck Rack

Zhe-ran Liu

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Zhe-ran

Contact Zhe-ran, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Limosilactobacillus reuteri for oral mucositis in patients undergoing radiotherapy for malignant head and neck tumors: a randomized controlled trial

|
By Kun Gao, Yi-Yan Pei, Zhi-Hui Li, Zheng Jiang, Yu Hua min, Ping Ai, Shu-ming Ji, Wen-Yan Guo, Yuan-tai Li, Jia-gang He, Zhe-ran Liu, Zi-xia Li, Xing-chen Peng
| Nature Verified
Abstract Oral mucositis (OM) is a major toxicity in patients with head and neck cancer undergoing radiotherapy. Here we conducted a double-blind, placebo-controlled, randomized phase II trial (NCT06285591) from March 2024 to January 2025 at West China Hospital of Sichuan University to evaluate whether Limosilactobacillus reuteri (L. reuteri) supplementation could reduce severe OM (SOM; WHO Oral Toxicity criteria grade ≥3). A total of 160 patients were randomly assigned to receive L.
Open in Who Shared Issue with article?
See all 1 articles